Transient Pseudohypoaldosteronism Affecting Children With Urinary Tract Malformation
TPHA
1 other identifier
observational
50
1 country
1
Brief Summary
Pseudohypoaldosteronism is a pathology affecting children under 6 months of age, little known but which can have serious consequences. There are no real figures on the prevalence of this pathology in France. The exact pathophysiology is not known and the management is not currently codified. This is why it is interesting to study this pathology and its treatment on a national scale in order to think about the best possible treatment, as well as to raise awareness of this pathology among different health professionals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 31, 2024
CompletedFirst Submitted
Initial submission to the registry
July 8, 2024
CompletedFirst Posted
Study publicly available on registry
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 1, 2025
July 1, 2024
1.8 years
July 8, 2024
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
National comparison of clinical and therapeutic practices concerning the management of pseudohypoaldosteronism in children with urinary malformations and/or urinary infections
This study compares clinical and therapeutic practices The retrospective analysis of the data will be carried out using classic statistical tests (Student's test, Fisher's test, ROC curve)
Up to 1 year
Eligibility Criteria
Minor subjects aged less than 6 years at the time of diagnosis of pseudohypoaldosteronism in the context of urinary malformation and/or urinary infection between January 1, 2018 and December 31, 2023
You may qualify if:
- Minor subjects aged less than 6 years at the time of diagnosis
- Diagnosis of pseudohypoaldosteronism in the context of urinary malformation and/or urinary infection between January 1, 2018 and December 31, 2023
- Subject (and/or their parental authority) having not expressed, after information, their opposition to the reuse of their data for the purposes of this research.
You may not qualify if:
- Subject (or their parents) having expressed their (their) opposition to participating in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, 67091, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2024
First Posted
April 1, 2025
Study Start
January 31, 2024
Primary Completion
December 1, 2025
Study Completion
December 31, 2025
Last Updated
April 1, 2025
Record last verified: 2024-07